101. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression.
- Author
-
Hollis JH, Lemus M, Evetts MJ, and Oldfield BJ
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Anti-Inflammatory Agents, Non-Steroidal antagonists & inhibitors, Anti-Inflammatory Agents, Non-Steroidal metabolism, Anti-Inflammatory Agents, Non-Steroidal toxicity, Eating drug effects, Energy Metabolism drug effects, Gene Expression Regulation drug effects, Gene Expression Regulation physiology, Hypothalamus drug effects, Inflammation Mediators administration & dosage, Inflammation Mediators antagonists & inhibitors, Inflammation Mediators metabolism, Inflammation Mediators toxicity, Injections, Intraventricular, Male, Neuropeptides physiology, Rats, Rats, Sprague-Dawley, Recombinant Proteins administration & dosage, Eating physiology, Energy Metabolism physiology, Hypothalamus metabolism, Interleukin-10 administration & dosage, Lipopolysaccharides antagonists & inhibitors, Lipopolysaccharides toxicity, Proto-Oncogene Proteins c-fos biosynthesis
- Abstract
Lipopolysaccharide (LPS) is often used to mimic acute infection and induces hypophagia, the selective partitioning of fat for energy, and fever. Interleukin-10 (IL-10) is an anti-inflammatory cytokine expressed in the brain which attenuates LPS-induced hypophagia; however the potential sites of interaction within the brain have not been investigated. Hypothalamic orexin (ORX) and melanin-concentrating hormone (MCH) regulate energy expenditure and food intake although the regulation of these neuropeptides through the interactions between central IL-10 and the inflammatory consequences of peripheral LPS have not been investigated. The present study in the rat investigated during the dark phase of the light-dark cycle the ability of central IL-10 (250 ng, i.c.v.) to attenuate the changes in food intake, energy substrate partitioning, and central Fos expression within the hypothalamus to peripheral LPS (100 microg/kg, i.p.); Fos expression changes specifically within ORX and MCH neurons were also investigated. Central IL-10 attenuated the peripheral LPS-induced hypophagia, reduction in motor activity, fever and reduction in respiratory exchange ratio. Central IL-10 also attenuated peripheral LPS-induced increases in Fos expression within ORX neurons and decreases in Fos expression within unidentified cells of the caudal arcuate nucleus. In contrast, both IL-10 and LPS injection independently decreased Fos expression within MCH neurons. The present study provides further insight into the interactions within the brain between the anti-inflammatory cytokine IL-10, the inflammatory consequences of LPS, and neuropeptides known to regulate energy expenditure and food intake., (Copyright 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF